FDA alerts providers to lack of sterility in NuVision Pharmacy products

Share this article:

The Food and Drug Administration expanded an alert about NuVision Pharmacy of Dallas, TX, on Saturday. It said investigators found poor sterile production practices that raised concern about a lack of sterility assurance for the company's sterile drug products.

NuVision recalled methylcobalamin injection (a form of Vitamin B12 injection) and lyophilized injection (freeze-dried powder) products in April because of a lack of sterility assurance and problems with quality control processes. Microbial contamination in a drug product can put a patient or resident at a serious infection risk, the FDA said.

Healthcare providers should check their medical supplies for NuVision sterile products, quarantine them and not give them to patients or residents, the FDA warned. Providers and consumers should report adverse reactions or problems to MedWatch

Share this article:

Next Article in Products

More in Products

LeadingAge's CAST releases EHR matrix selection tool

LeadingAge's Center for Aging Services Technologies released its 2014 version of a tool to let long-term providers choose the best electronic health record for their facility.

New magnetic badges debut

New magnetic badges debut

Imprint Plus has introduced The Mighty Badge name badge kit, which allows users to create reusable but personalized badges.

Hollister Incorporated celebrates antibacterial foam dressing

Hollister Incorporated celebrates antibacterial foam dressing ...

Hollister Incorporated's new Hydrofera Blue Ready antibacterial foam dressing has been named a "Top 10 Innovation in Podiatry" according to the Podiatry Today journal, as well as a "Top Innovation ...